Kevin O’Reilly

RPO, Inc. is incorporated in Delaware and has headquarters in San Jose. The core technologies have been developed at its research and development facilities in Canberra and Sydney, Australia. It has received venture funding from existing investors including Australian funds managed by Jolimont Capital, by Allen & Buckeridge and by Neo Technology Ventures; and from BASF Venture Capital and from Jafco. Since mid-2003 RPO's focus has been turned to applying its waveguide technology to solutions for consumer electronics markets and developing a high-volume manufacturing process. They are a technology focused company, with over 90% of its staff engaged in waveguide technology development, technical marketing, product development, design, and manufacturing. Die design, layout and footprint is customized to suit customers' cost, performance, assembly and packaging requirements. RPO supplies the key component to its touch screen customers the polymer optical waveguides for integration during the final product's assembly process.

Photon Dynamics, Inc. manufactures test inspection and repair systems for the flat panel display industry. The company was founded on May 12, 1986 and is headquartered in San Jose, CA.

Pioneer Electronics USA, Inc. manufactures consumer and commercial electronics. Its products include AppRadio, GPS navigation, DVD receivers, CD receivers, digital media receivers, speakers, subwoofers, amplifiers and accessories. The company was founded in 1972 and is headquartered in Long Beach, CA.

Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Proton Solutions segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA.